"FOR SHARP REES-STEALY PATIENTS: * For the health and safety of all, no one may accompany a patient to any visit at Sharp Rees-Stealy unless absolutely necessary. If you have COVID-19 symptoms such as a fever or respiratory symptoms such as cough, sore throat or shortness of breath, please contact us first before coming to this location. Laboratory services are available by appointment only.* At Sharp Rees-Stealy La Mesa, you'll find us when and where you need us. Our primary care physicians and specialists — as well as radiology, laboratory and pharmacy — are all here and ready for you. We offer same-day or next-day primary care appointments and after-hours pediatric appointments with our La Mesa doctors."

During the past decade, Sharp Rees-Stealy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sharp Rees-Stealy" are "Non Small Cell Lung Carcinoma" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Sharp Rees-Stealy" in a lesser frequency.

Most popular intervention types in "Sharp Rees-Stealy" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "TLK286 (Telcyta) HCl for Injection" (1 trials), "TLK286 HCl for injection" (1 trials), "doxorubicin HCl liposome injection" (1 trials), "gefitinib (Iressa)" (1 trials) and "topotecan hydrochloride for injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sharp Rees-Stealy" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sharp Rees-Stealy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Sharp Rees-Stealy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sharp Rees-Stealy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".